Clinical trial
Performance of Nevisense Electrical Impedance Spectroscopy in Patients With Multiple Nevi and Large Acquired Nevi (LAN)
NCT04705168 is registered in ClinicalTrials.gov with Memorial Sloan Kettering Cancer Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Performance of Nevisense Electrical Impedance Spectroscopy in Patients With Multiple Nevi and Large Acquired Nevi (LAN)
- Lead sponsor
- Memorial Sloan Kettering Cancer Center
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 8, 2021
- Completion date
- November 18, 2025
- Enrollment
- 40 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
large acquired nevi, multiple nevi, nevus, skin lesion